未找到相关数据
Independent validation of the HER2DX genomic test in HER2-positive breast cancer treated with neoadjuvant paclitaxel, trastuzumab and pertuzumab (THP): a correlative analysis from the DAPHNe phase II clinical trial
被引：0
作者：
Waks, Adrienne
Ogayo, Esther R.
Pare, Laia
Marin-Aguilera, Mercedes
Braso-Maristany, Fara
Galvan, Patricia
Castillo, Oleguer
Martinez-Saez, Olga
Vivancos, Ana
Villagrasa, Patricia
Tarantino, Paolo
Desai, Neelam
Guerriero, Jennifer
Metzger, Otto
Tung, Nadine
Krop, Ian
Parker, Joel S.
Perou, Charles M.
Prat, Aleix
Winer, Eric
Tolaney, Sara
Mittendorf, Elizabeth A.
机构：
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-04-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-04-05
引用
收藏
页数：3
相关论文